This site is intended for health professionals only

Wednesday 24 April 2019

Ioannis Parodis MD PhD

Articles by this author

Tue 2 April
Tue 2 April
The SLE populations of the pivotal BLISS-52 and BLISS-76 trials constitute large patient cohorts, ideal for post-hoc survey to better understand the disease itself, and the effects of belimumab treatment
Thu 6 December
Thu 6 December
Observations from a Phase II trial support further development of ustekinumab as a new therapy for SLE, and results from Phase III trials are awaited
Tue 2 October
Tue 2 October
There is now a better understanding of autoimmunity in systemic lupus erythematosus, which has led to improved therapeutic strategies, but revolutionary treatments have yet to be discovered